Approval · Notice of Compliance 35965 · 2025
VLOOP: Notice of Compliance 35965
Issued September 5, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35965
- Date
- September 5, 2025
- Company
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- NUVARING (Merck Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VLOOP | 02560887 | Approved |
Medicinal ingredients
- ETHINYL ESTRADIOL 3.474 MG per RING
- ETONOGESTREL 11 MG per RING